Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001441404) titled 'Investigating Effects of Estrogen Blockade on Androgenic Steroid Profile in Healthy Women' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Primary Sponsor: Concord Hospital Andrology Department
Condition:
Reproductive health
Reproductive health
Metabolic and Endocrine - Other endocrine disorders
Intervention:
5 days of estrogen blockade therapy with either Clomifene or Letrozole.
Clomifene 50mg oral tablet. 1 tablet daily for 5 days.
Patients will be given 5 tablets on day 1 of t...